Comparison of 50-mg and 100-mg sustained-release isosorbide mononitrate in the treatment of stable angina pectoris: Effects on quality-of-life indices

Current Therapeutic Research - Clinical and Experimental

Volumn 59, Issue 7, 1998, Pages 511-519

  Zwinderman, Aeilko H ^a   Cleophas, Ton J M ^b   Niemeyer, Menco G ^a   Van Der Wall, Ernst E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Merwede Ziekenhuis   (Netherlands)

Author keywords

Isosorbide mononitrate; Quality of life; Stable angina pectoris; Sustained release

Indexed keywords

ISOSORBIDE MONONITRATE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISTRESS SYNDROME; DRUG EFFICACY; DRUG SCREENING; FEMALE; HUMAN; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; SUSTAINED RELEASE PREPARATION;

EID: 0031859459     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(98)85088-1     Document Type: Article

References (24)

1. Niemeyer GG, Kleinjans HA, De Ree R, et al, on behalf of the Dutch Mononitrate Quality of Life Study Group. Comparison of multiple-dose and once-daily nitrate therapy in patients with stable angina pectoris. Curr Ther Res. 1996;57:927-936.
2. Thadani U, Maranda CR, Amsterdam E, et al. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate. Ann Intern Med. 1994;120:353-359.
3. Chrysant SG, Glasser SP, Bittar N, et al. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris. Am J Cardiol. 1993;72:1249-1256.
4. Kohli RS, Rodrigues EA, Kardash MM, et al. Acute and sustained effects of isosorbide-5-mononitrate in stable angina pectoris. Am J Cardiol. 1986;58:727-731.
5. Thadani U, Prasad R, Hamilton SF, et al. Usefulness of twice-daily isosorbide-5-mononitrate in preventing the development of tolerance in angina pectoris. Am J Cardiol. 1987;60:477-482.
6. Ferratini M, Pirelli S, Merlini P, et al. Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: A comparison with a continuous schedule. Eur Heart J. 1989;10:998-1002.
7. Parker JO, Amies MH, Hawkinson RW, et al. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group. Circulation. 1995;91:1368-1374.
8. Olsson G, Allgen J, Amtorp O, et al. Absence of predose rebound phenomena with once daily 5-ISMN in a controlled-release formulation. Eur Heart J. 1992;13:814-817.
9. Lee ML, Lusher JM. The problem of therapeutic equivalence with paired qualitative data: An example from a clinical trial using haemophiliacs with an inhibitor to factor VIII. Stat Med. 1991;10:433-441.
10. Cleophas TJ, Tavenier P. Fundamental issues of choosing the right type of trial. Am J Ther. 1994;1:327-332.
11. Cleophas TJ. A simple analysis of crossover studies with one-group interaction. Int J Clin Pharmacol Ther. 1995;33:322-327.
12. Cleophas TJ. Underestimation of treatment effect in crossover trials. Angiology. 1990; 41:673-679.
13. Louis TA, Lavori PW, Bailar JC, Polansky M. Crossover and self-controlled designs in clinical research. NEJM. 1984;310:24-31.
14. Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: New outcome measure for primary care. BMJ. 1992;305:160-164.
15. Wilson A, Wiklund I, Lahti T, Wahl M. A summary index for the assessment of quality of life in angina pectoris. J Clin Epidemiol. 1991;44:981-988.
16. Zwinderman AH. Response models with manifest predictors. In: Van der Linden W, Hambleton RK, eds. Handbook of Modern Item Response Therapy. Berlin: Springer Verlag; 1995:175-195.
17. Bland JM, Altman DG. Statistics notes. Cronbach's alpha. BMJ. 1997;314:572-573.
18. Walldius G, Regnström J, Nilsson J, et al. The role of lipids and antioxidative factors for development of atherosclerosis. The Probucol Quantitative Regression Swedish Trial (PQRST). Am J Cardiol. 1993;71:15-19.
19. Quyyami AA, Panza AA, Diodati JG, et al. Prognostic implications of myocardial ischemia during daily life in low risk patients with coronary artery disease. J Am Coll Cardiol. 1993;21:700-708.
20. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. NEJM. 1996;334:835-840.
21. Albert SM, Frank L, Murri R, et al. Defining and measuring quality of life in medicine. JAMA. 1998;279:429-431.
22. Demots H, Glasser SP. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina pectoris. J Am Coll Cardiol. 1989;13:786-795.
23. Marquis P, Fayol C, Joire JE. Clinical validation of life questionnaire in angina pectoris patients. Eur Heart J. 1995;16:1554-1560.
24. Parker JD, Parker JO. Nitrate therapy for stable angina pectoris. NEJM. 1998;338:520-531.